https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-oral-antiviral-treatment-covid-19
【 在 headmasters 的大作中提到: 】
: The primary data supporting this EUA for Paxlovid are from EPIC-HR, a random
: ized, double-blind, placebo-controlled clinical trial studying Paxlovid for
: the treatment of non-hospitalized symptomatic adults with a laboratory confi
: ...................
--
FROM 223.97.55.*